Wilson's Disease

Therapeutics of Parkinson's Disease and Other Movement Disorders

Volumn , Issue , 2008, Pages 251-261

  Brewer, George J ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Anti copper drugs; Therapeutics; Treatment of phases; Wilson's disease

Indexed keywords

EID: 84868596762     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470713990.ch16     Document Type: Chapter

References (62)

1. Askari, F.K., Greenson, J., Dick, R.D. et al. (2003) Treatment of Wilson's disease with zinc. XVIII. Initial treatment of the hepatic decompensation presentation with trientine and zinc. The Journal of Laboratory and Clinical Medicine, 142, 385-390.
2. Bremner, I., Mills, C.F. and Young, B.W. (1982) Copper metabolism in rats given di-or trithiomolybdates. Journal of Inorganic Biochemistry, 16, 109-119.
3. Brewer, G.J., Schoomaker, E.B., Leichtman, D.A. et al. (1977) The uses of pharmacologic doses of zinc in the treatment of sickle cell anemia, in Zinc Metabolism: Current Aspects in Health and Disease (eds G.J. Brewer and A.S. Prasad), Allan R. Liss, Inc., New York.
4. Brewer, G.J., Hill, G.M., Prasad, A.S. et al. (1983) Oral zinc therapy for Wilson's disease. Annals of Internal Medicine, 99, 314-319.
5. Brewer, G.J., Terry, C.A., Aisen, A.M. and Hill, G.M. (1987) Worsening of neurologic syndrome in patients with Wilson's disease with initial penicillamine therapy. Archives of Neurology, 44, 490-493.
6. Brewer, G.J., Yuzbasiyan-Gurkan, V. and Dick, R. (1990) Zinc therapy of Wilson's disease: VIII. Dose response studies. The Journal of Trace Elements in Experimental Medicine, 3, 227-234.
7. Brewer, G.J., Dick, R.D., Yuzbasiyan-Gurkan, V. et al. (1991) Initial therapy of patients with Wilson's disease with tetrathio-molybdate. Archives of Neurology, 48, 42-47.
8. Brewer, G.J., Yuzbasiyan-Gurkan, V. and Johnson, V. (1991) Treatment of Wilson's disease with zinc. IX: Response of serum lipids. The Journal of Laboratory and Clinical Medicine, 118, 466-470.
9. Brewer, G.J. and Yuzbasiyan-Gurkan, V. (1992) Wilson's disease. Medicine, 71, 139-164.
10. Brewer, G.J., Yuzbasiyan-Gurkan, V., Johnson, V. et al. (1993a) Treatment of Wilson's disease with zinc XII: dose regimen requirements. The American Journal of the Medical Sciences, 305, 199-202.
11. Brewer, G.J., Yuzbasiyan-Gurkan, V., Johnson, V. et al. (1993b) Treatment of Wilson's disease with zinc: XI. Interaction with other anticopper agents. Journal of the American College of Nutrition, 12, 26-30.
12. Brewer, G.J., Dick, R.D., Johnson, V. et al. (1994a) Treatment of Wilson's disease with ammonium tetrathiomolybdate. I. Initial therapy in 17 neurologically affected patients. Archives of Neurology, 51, 545-554.
13. Brewer, G.J., Dick, R.D., Yuzbasiyan-Gurkan, V. et al. (1994b) Treatment of Wilson's disease with zinc. XIII: Therapy with zinc in presymptomatic patients from the time of diagnosis. The Journal of Laboratory and Clinical Medicine, 123, 849-858.
14. Brewer, G.J., Johnson, V., Dick, R.D. et al. (1996) Treatment of Wilson's disease with ammonium tetrathiomolybdate. II. Initial therapy in 33 neurologically affected patients and follow-up with zinc therapy. Archives of Neurology, 53, 1017-1025.
15. Brewer, G.J., Johnson, V. and Kaplan, J. (1997) Treatment of Wilson's disease with zinc: XIV. Studies of the effect of zinc on lymphocyte function. The Journal of Laboratory and Clinical Medicine, 129, 649-652.
16. Brewer, G.J., Dick, R.D., Johnson, V.D. et al. (1998) Treatment of Wilson's disease with zinc: XV long-term follow-up studies. The Journal of Laboratory and Clinical Medicine, 132, 264-278.
17. Brewer, G.J. (2000) Recognition, diagnosis, and management of Wilson's disease. Experimental Biology and Medicine, 223, 39-46.
18. Brewer, G.J., Johnson, V.D., Dick, R.D. et al. (2000) Treatment of Wilson's disease with zinc XVII: Treatment during pregnancy. Hepatology, 31, 364-370.
19. Brewer, G.J. (2001) Wilson's Disease: A Clinician's Guide to Recognition, Diagnosis, and Management, Kluwer Academic Publishers, Boston, MA.
20. Brewer, G.J., Dick, R.D., Johnson, V.D. et al. (2001) Treatment of Wilson's disease with zinc XVI: treatment during the pediatric years. The Journal of Laboratory and Clinical Medicine, 137, 191-198.
21. Brewer, G.J., Hedera, P., Kluin, K.J. et al. (2003) Treatment of Wilson's disease with ammonium tetrathiomolybdate: III. Initial therapy in a total of55 neurologically affected patients and follow-up with zinc therapy. Archives of Neurology, 60, 379-385.
22. Brewer, G.J. (2004) Wilson's disease, in Harrison's Principles of Internal Medicine, 16th edn, (eds D.L. Kasper E. Braunward A.S. Fauci S.L. Hauser D.L. Longo and J.L. Jameson), McGraw-Hill Companies, Inc., New York, NY.
23. Brewer, G.J. (2005) Behavioral abnormalities in Wilson's disease, in Behavioral Neurology of Movement Disorders 2nd edn, (eds W.J. Weiner A.E. Lang and K.E. Anderson), Lippincott, Williams & Wilkins, Philadelphia.
24. Brewer, G.J., Askari, F., Lorincz, M.T. et al. (2006) Treatment of Wilson's disease with ammonium tetrathiomolybdate: IV. Comparison of tetrathiomolybdate and trientine in a double-blind study of treatment of the neurologic presentation of Wilson's disease. Archives of Neurology, 63, 521-527.
25. Bull, P.C., Thomas, G.R., Rommens, J.M. et al. (1993) The Wilson's disease gene is a putative copper transporting P-type ATPase similar to the Menkes gene. Nature Genetics, 5, 327-337.
26. Chandra, R.K. (1984) Excessive intake of zinc impairs immune responses. Journal of the American Medical Association, 252, 1443-1446.
27. Czlonkowska, A., Gajda, J. and Rodo, M. (1996) Effects of long-term treatment in Wilson's disease with D-penicillamine and zinc sulphate. Journal of Neurology, 243, 269-273.
28. Dhawan, A., Taylor, R.M., Cheeseman, P. et al. (2005) Wilson's disease in children: 37-year experience andrevised King's score for liver transplantation. Liver Transplantation, 11, 441-448.
29. Dick, A.T. and Bull, L.B. (1945) Some preliminary observations of the effect of molybdenum on copper metabolism in herbivorous animals. Australian Veterinary Journal, 21, 70-72.
30. Ferguson, W.S., Lewis, A.L. and Waterson, S.J. (1943) The teart pastures of Somerset, I:the cause and cure of teartness. Journal of Agriculture Science, 33, 44.
31. Gooneratne, S.R., Howell, J.M. and Gawthorne, J.M. (1981) An investigation of the effects of intravenous administration of thiomolybdate on copper metabolism in chronic Cu-poisoned sheep. The British Journal of Nutrition, 46, 469-480.
32. Hall, A.C., Young, B.W. and Bremner, I. (1979) Intestinal me-tallothionein and the mutual antagonism between copper and zinc in the rat. Journal of Inorganic Biochemistry, 11, 57-66.
33. Hill, G.M., Brewer, G.J., Juni, J.E. et al. (1986) Treatment of Wilson's disease with zinc. II. Validation of oral 64copper with copper balance. The American Journal of the Medical Sciences, 292, 344-349.
34. Hill, G.M., Brewer, G.J., Prasad, A.S. et al. (1987) Treatment of Wilson's disease with zinc. I. Oral zinc therapy regimens. Hepatology, 7, 522-528.
35. Hoogenraad, T.U., Van den Hammer, C.J.A., Koevoet, R. and De Ruyter Korver, E.G.W.M. (1978) Oral zinc in Wilson's disease. Lancet, 2, 1262-1263.
36. Hoogenraad, T.U., Koevoet, R. and de Ruyter Korver, E.G. (1979) Oral zinc sulphate as long-term treatment in Wilson's disease (hepatolenticular degeneration). European Neurology, 18, 205-211.
37. Hoogenraad, T.U., Van Hattum, J. and Van den Hamer, C.J.A. (1987) Management of Wilson's disease with zinc sulfate. Experience in a series of 27 patients. Journal of the Neurological Sciences, 77, 137-146.
38. Hoogenraad, T.U. (1996) Wilson's Disease, Saunders, London.
39. Marcellini, M., Di Ciommo, V., Callea, F. et al. (2005) Treatment of Wilson's disease with zinc from the time of diagnosis in pediatric patients: a single-hospital, 10-year follow-up study. The Journal of Laboratory and Clinical Medicine, 145, 139-143.
40. Marcilese Ammerman, C.B., Valsecchi, R.M., Dunavant, B.G. and Davis, G.K. (1969) Effect of dietary molybdenum and sulfate upon copper metabolism in sheep. Journal of Nutrition, 99, 177-183.
41. Mason, J. (1990) The biochemical pathogenesis of molybdenum-induced copper deficiency syndromes in ruminants: towards the final chapter. Irish Veterinary Journal, 43, 18-21.
42. McQuaid, A. and Mason, J. (1991) A comparison of the effects of penicillamine, trientine, and trithiomolybdate on [35S]-labeled metallothionein in vitro; implications for Wilson's disease therapy. Journal of Inorganic Biochemistry, 41, 87-92.
43. Menard, M.P., McCormick, C.C. and Cousins, R.J. (1981) Regulation of intestinal metallothionein biosynthesis in rats by dietary zinc. The Journal of Nutrition, 111, 1353-1361.
44. Miller, R.F. and Engel, R.W. (1960) Interrelations of copper, molybdenum and sulfate sulfur in nutrition. Federation Proceedings, 19, 666-677.
45. Mills, C.F., El-Gallad, T.T. and Bremner, I. (1981) Effects of molybdate, sulfide, and tetrathiomolybdate on copper metabolism in rats. Journal of Inorganic Biochemistry, 14, 189-207.
46. Mills, C.F., El-Gallad, T.T., Bremner, I. and Weham, G. (1981) Copper and molybdenum absorption by rats given ammonium tetrathiomolybdate. Journal of Inorganic Biochemistry, 14, 163-175.
47. Nazer, H., Ede, R.J., Mowat, A.P. and Williams, R. (1986) Wilson's disease: clinical presentation and use of prognostic index. Gut, 27, 1377-1381.
48. Nimni, M.E. and Bavetta, L.A. (1965) Collagen defect induced by penicillamine. Science, 150, 905-907.
49. Oestreicher, P. and Cousins, R.J. (1985) Copper and zinc absorption in the rat: mechanism of mutual antagonism. The Journal of Nutrition, 115, 159-166.
50. Physicians Desk Reference (2007) Montvale, NJ, Thomson PDR.
51. Prasad, A.S., Brewer, G.J., Schoomaker, E.B. and Rabbini, P. (1978) Hypocupremia induced by zinc therapy in adults. The Journal of the American Medical Association, 240, 2166-2168.
52. Ronchetti, I.P., Fornieri, C., Contri, M.B. et al. (1986) Effect of DL-penicillamine on the aorta of growing chickens. American Journal of Pathology, 124, 436-447.
53. Scheinberg, I.H. and Sternlieb, I. (1984) Wilson's disease, in Major Problems in Internal Medicine (ed. L.H.J. Smith), W.B. Saunders Company, Philadelphia.
54. Schouwink, G. (1961) De hepatocecerebrale degeneratie, met een onderzoek naar de zonkstr of wisseling. MD thesis (with a summary in English, French, and German). University of Amsterdam.
55. Starosta-Rubinstein, S., Young, A.B., Kluin, K. et al. (1987) Clinical assessment of 31 patients with Wilson's disease. Correlations with structural changes on magnetic resonance imaging. Archives of Neurology, 44, 365-370.
56. Tanzi, R.E., Petrukhin, K., Chernov, I. et al. (1993) The Wilson's disease gene is a copper transporting ATPase with homology to the Menkes disease gene. Nature Genetics, 5, 344-350.
57. Walshe, J.M. (1956) Penicillamine, a new oral therapy for Wilson's disease. American Journal of Medicine, 21, 487-495.
58. Walshe, J.M. (1982) Treatment of Wilson's disease with trientine (triethylene tetramine) dihydrochloride. Lancet, 1, 643-647.
59. Yamaguchi, Y., Heiny, M.E. and Gitlin, J.D. (1993) Isolation and characterization of a human liver cDNA as a candidate gene for Wilson's disease. Biochemical and Biophysical Research Communications, 197, 271-277.
60. Yuzbasiyan-Gurkan, V., Brewer, G.J., Abrams, G.D. et al. (1989) Treatment of Wilson's disease with zinc. V. Changes in serum levels of lipase, amylase, and alkaline phosphatase in patients with Wilson's disease. The Journal of Laboratory and Clinical Medicine, 114, 520-526.
61. Yuzbasiyan-Gurkan, V., Johnson, V. and Brewer, G.J. (1991) Diagnosis and characterization of presymptomatic patients with Wilson's disease and the use of molecular genetics to aid in the diagnosis. Journal of Laboratory & Clinical Medicine, 118, 458-465.
62. Yuzbasiyan-Gurkan, V., Grider, A., Nostrant, T. et al. (1992) Treatment of Wilson's disease with zinc: X. Intestinal metal-lothionein induction. The Journal of Laboratory and Clinical Medicine, 120, 380-386.